Delivery Order SPE2DB20D3505-SPE2DB24FV1D0

Award Date 9/27/24
Potential Completion Date 9/30/24
Potential Value $6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,294.67 firm fixed-price contract provides 300 mg Lamotrigine ER tablets to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order, valued at $1,995.26, is for the supply of Lamotrigine ER 250 mg tablets. The contract is a firm-fixed-price Delivery Order with an ultimate completion date of September 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lamotrigine ER 50 mg tablets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $6,896.92 and runs through April 30, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp to provide Lamotrigine ER 50 mg tablets. The award is a Delivery Order issued under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a wide range of pharmaceutical and medical supplies from AmerisourceBergen to support military healthcare programs and facilities worldwide....
The federal contract award is for the supply of the medication Lamotrigine ER 250 mg tablets to the Defense Logistics Agency (DLA). The $4,284.45 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 9, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lamotrigine ODT 50 mg tablets, a medication used to treat certain types of seizures. The contract has a ceiling value of $20,267.48 and is a firm fixed-price, non-set-aside contract with a period of performance through May 9, 2025. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,944.30, is for the delivery of Lamotrigine ODT 100 mg tablets. This is a delivery order contract with a firm-fixed price pricing type. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lamotrigine ER 200 mg Tablets in quantities of 30. The $3,349.80 contract is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of August 18, 2022 and was awarded on August 17, 2022. The contract is not designated with a set-aside requirement, indicating open competition....
This is a $1,065.82 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 30-count bottles of 200 mg Lamotrigine ER tablets, which are used to treat certain types of seizures. The contract has a completion date of June 24, 2025 and is not set aside for any small business category. AmerisourceBergen Drug Corp is the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,264.60 firm-fixed-price delivery order is for the supply of Lamotrigine ER 50 mg tablets. This contract is a child award under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB24FV1D0
    Delivery Order

This is a delivery order (SPE2DB20D3505|SPE2DB24FV1D0) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lamotrigine ER 50 mg tablets. The $6,003.67 firm-fixed-price contract has an ultimate completion date of September 30, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 11:17 AM